Outcome of 10 children with hepatoblastoma.
|
Accession number;02A0934758
|
| Title;Outcome of 10 children with hepatoblastoma. |
| Author;
NISHIMURA SHIN'ICHIRO
(Hiroshima Univ., Sch. of Med.)
SATO TAKASHI
(Hiroshima Univ., Sch. of Med.)
UEDA HARUO
(Hiroshima Univ., Sch. of Med.)
UEDA KAZUHIRO
(Hiroshima Univ., Sch. of Med.)
YAMAOKA HIROAKI
(Hiroshima Univ., Sch. of Med.)
HIYAMA EISO
(Hiroshimadai I Sogoshinryobu)
YOKOYAMA TAKASHI
(Hiroshimadai I Sogoshinryobu)
|
Journal Title;Japanese Journal of Pediatric Oncology
|
Journal Code:X0797A
|
ISSN:0389-4525
|
|
VOL.39;NO.2;PAGE.171-176(2002)
|
| Figure&Table&Reference;FIG.3, TBL.2, REF.14 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;10 cases with incipient hepatoblastoma(6-months- 10 years old; 8 males and 2 females) treated in the past decade are outlined. 2 cases with early stage received drip infusion of CDDP/DXR therapy, and 8 cases with more advanced stage received continuous infusion of CDDP and DXR therapy(some of the cases did CDDP/VCR/5-FU therapies alternately). 2 cases with Stage IV, and 1 case with recurrence after chemotherapy, additionally received specific high-dose chemotherapy in combination with autologous stem cell transplantation. At present, all 10 cases survive in remission. 2 cases received CDDP/DXR therapy to result in onset of drug-induced cardiomyopathy as the late disorder. Then the 2 cases received chemotherapy. The following were shown in figures or tables: regimens of chemotherapy, the outline of cases(sex, age, stage of disease, pathological diagnosis), clinical results, measures for treatment and the prognosis, and our treatment program for hepatoblastoma. |
|
|
|
Related Articles;
|
|
